Journal profile · Toxicology
NeuroToxicology
ISSN 0161-813X · eISSN 1872-9711 · Elsevier · NETHERLANDS · Bimonthly · Founded 1979
NeuroToxicology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.78; hybrid open access; APC about USD 4,030; median 92 days to acceptance (107 articles, last 24 months); community-reported acceptance: about 41.66%; 140 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
NeuroToxicology is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heavy Metal Exposure and Toxicity, Neuroscience and Neuropharmacology Research and Pesticide Exposure and Toxicity, together about 30.7% of its articles. Its main subfields are Health, Toxicology and Mutagenesis. (generated from OpenAlex topic counts and CAS ranking data)
Affiliated with the International Neurotoxicology AssociationNeuroToxicology specializes in publishing peer-reviewed original research papers describing the effects of toxic substances on the nervous system across the lifespan as determined in humans and/or experimental models (in vivo, in vitro, in silico). The Journal welcomes papers dealing with the neurotoxic effects of occupationally and environmentally relevant exposures to agents (chemical, physical, biological, pharmacological or naturally occurring), singly or in mixtures, including complex mixtures, such as air pollution. Papers describing neurotoxic outcomes associated with natural disasters, industrial accidents, and terrorist attacks are also welcome.Experimental (animal, in vitro, in silico) papers focused on the neurotoxic effects of undefined commercial formulas (i.e., pesticide formulations) will be considered only if the authors report the chemical composition of the formulation and/or determine whether neurotoxic effects are due to the active chemical ingredient(s), carrier, or combination. For human studies, the components of formulations or other mixtures should be identified, but if not available, the source of exposure (i.e. commercial formulation, air pollution, wildfires, hurricanes, and other natural or industrial disasters) should be described as fully as possible.NeuroToxicology welcomes papers describing interventions for mitigating or reversing neurotoxic outcomes, but will accept papers reporting on neuroprotective or neurorestorative properties of formulations, botanical extracts, or other natural products only if full chemical identification and purification information of the active molecule(s) is provided. NeuroToxicology does not accept case reports.
From the journal's Aims & Scope
Research area (LetPub): Toxicology
Editor-in-chief Pamela J. LeinPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 80, Germany 6, Mexico 6, Netherlands 4, Spain 3 (114 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Heavy Metal Exposure and ToxicityEnvironmental Science13%
- Neuroscience and Neuropharmacology ResearchNeuroscience9.5%
- Pesticide Exposure and ToxicityAgricultural and Biological Sciences8.2%
- Trace Elements in HealthNursing5.8%
- Mercury impact and mitigation studiesEnvironmental Science4.8%
- Anesthesia and Neurotoxicity ResearchNeuroscience4.7%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.7%
- Parkinson's Disease Mechanisms and TreatmentsMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Toxicology | Zone 2 |
| Minor | Neurosciences | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Neurosciences | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Toxicology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Toxicology | Zone 3 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.78LetPub ·
- Impact factor (publisher)
- 3.8Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- SJR 2026-06
- 1.03LetPub ·
- SNIP 2026-06
- 1.02LetPub ·
- h-index
- 102LetPub ·
- h-index
- 142OpenAlex ·
- i10-index
- 2,556OpenAlex ·
- 2-year mean citedness
- 2.87OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 17.18%LetPub ·
Volume
- Articles per year
- 121LetPub ·
Articles by year OpenAlex count · 3,958 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 162 | 68 | 67 |
| 2025 | 140 | 48 | 394 |
| 2024 | 108 | 47 | 715 |
| 2023 | 129 | 53 | 1,405 |
| 2022 | 161 | 63 | 2,924 |
| 2021 | 136 | 54 | 2,885 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 75 days – 123 days
- Acceptance to online
- median 2 days (107 articles)
- Submission to online
- median 95 days
- Sample
- 107 articles with submission and acceptance dates (324 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 41.66%LetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 44 daysPublisher website ·
- Submission to acceptance
- 92 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,030 / EUR 3,770 / GBP 3,230 / JPY 499,840 | — | — | |
| Publisher website | USD 4,200 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
- Not considered
- case reports
Article types accepted15
- brief communicationNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- brief communicationsBrief Communications. NeuroToxicology will publish brief reports of work that has progressed to the stage at which it is considered that the science of neurotox…Length not stated
- brief reportNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- commentariesCommentaries are welcome consisting of articles or essays on topics of contemporary interest that espouse or propose changes in environmental regulations, publi…Length not stated
- commentaryNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- featuresNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- forum "position papers"Forum. The Forum section "Position Papers" of the Journal will address, discuss, and present position papers on current issues in neurotoxicology.Length not stated
- letterNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- letters to the editorNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- original paperNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- original researchNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- original research articleNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- reviewNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- review articleNeuroToxicology will publish papers containing Original Research, Brief Communications, Reviews, Letters to the Editor, Forum "Position Papers," Commentaries an…Length not stated
- reviewsReviews. For review articles to be considered for publication, they should meet the following criteria:Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1979
- ISSN
- 0161-813X
- Electronic ISSN
- 1872-9711
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about NeuroToxicology
What CAS zone is NeuroToxicology in?
In the 2025 upgraded edition of the CAS Journal Ranking, NeuroToxicology is in Zone 3 of Medicine, and in Zone 2 of the minor category Toxicology / Neurosciences / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NeuroToxicology?
The latest impact factor listed by LetPub is 3.78; CiteScore 8, h-index 142.
How long does peer review take at NeuroToxicology?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 75–123 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 41.66%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of NeuroToxicology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of NeuroToxicology based?
Of the 114 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (80), Germany (6) and Mexico (6). Counted from the institutions listed on the board page; for reference only.
Which databases index NeuroToxicology?
According to LetPub and DOAJ records, NeuroToxicology is indexed in SCIE and Scopus.
Is NeuroToxicology open access, and what is the APC?
NeuroToxicology is a hybrid journal. For open-access publication: APC about USD 4,030.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .